title: Identification of a novel common genetic risk factor for lumbar disk disease.
abstract: BACKGROUND
  Lumbar disk disease (LDD) is one of the most common musculoskeletal diseases, with a prevalence of about 5%. A tryptophan (Trp) allele (Trp2) was recently discovered in the COL9A2 gene that is associated with dominantly inherited LDD but is only present in about 4% of Finnish patients with LDD.
  
  
  OBJECTIVE
  To determine if other collagen IX gene sequence variations play a role in the pathogenesis of LDD.
  
  
  METHODS
  Case-control study conducted from February 1997 to May 1998 at university hospitals in Finland.
  
  
  METHODS
  A total of 171 individuals with LDD (evaluated clinically and by magnetic resonance imaging or computed tomography) and 321 controls without LDD (186 healthy individuals, 83 patients with primary osteoarthritis, 31 with rheumatoid arthritis, and 21 with chondrodysplasias).
  
  
  METHODS
  Frequencies of sequence variations covering the entire coding sequences and exon boundaries of the collagen IX genes, COL9A1, COL9A2, and COL9A3, which code for the alpha1, alpha2, and alpha3 chains of the protein, detected by conformation-sensitive gel electrophoresis and confirmed by sequencing, compared between individuals with and without LDD.
  
  
  RESULTS
  Mutation analysis of all 3 collagen IX genes resulted in identification of an Arg103-->Trp (arginine-->tryptophan) substitution in the alpha3 chain (Trp3 allele). The frequency of the Trp3 allele was 12.2% in LDD cases, excluding 7 individuals who were carriers of the previously identified Gln326-->Trp (glutamine-->tryptophan) substitution in the alpha2 chain (Trp2 allele), and was 4.7% among controls. The difference in the frequency was statistically significant (P =.000013). Presence of at least 1 Trp3 allele increases risk of LDD about 3-fold.
  
  
  CONCLUSIONS
  This study led to the identification of a novel common genetic risk factor for LDD, confirming that genetic risk factors likely play a significant role in LDD.
authors: Department of Medical Biochemistry, University of Oulu, Aapistie 7, 90220 Oulu, Finland.
authors: P
authors: P
authors: Paassilta
authors: J
authors: J
authors: Lohiniva
authors: H H
authors: HH
authors: Göring
authors: M
authors: M
authors: Perälä
authors: S S
authors: SS
authors: Räinä
authors: J
authors: J
authors: Karppinen
authors: M
authors: M
authors: Hakala
authors: T
authors: T
authors: Palm
authors: H
authors: H
authors: Kröger
authors: I
authors: I
authors: Kaitila
authors: H
authors: H
authors: Vanharanta
authors: J
authors: J
authors: Ott
authors: L
authors: L
authors: Ala-Kokko
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D001120:Arginine; D016022:Case-Control Studies; D003094:Collagen / Q000235:genetics*; D024081:Collagen Type IX; D004252:DNA Mutational Analysis; D004586:Electrophoresis; D005387:Finland; D020022:Genetic Predisposition to Disease; D006801:Humans; D007405:Intervertebral Disc Displacement / Q000175:diagnosis / Q000235:genetics*; D008159:Lumbar Vertebrae; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D014364:Tryptophan / Q000235:genetics*
chemical_list: C120282:COL9A2 protein, human; C120768:COL9A3 protein, human; D024081:Collagen Type IX; D014364:Tryptophan; D003094:Collagen; D001120:Arginine